Coronavirus Disease 2019 (COVID-19) is causing unprecedented disruptions to the U.S. economy. Government officials and health professionals are predicting that these disruptions could continue through September. Businesses are having to
Continue Reading Risk Allocation for Economic Losses from Coronavirus Disease 2019

While it is too early to predict how long the Coronavirus Disease 2019 (COVID-19) will disrupt everyday life, it isn’t too soon to proactively consider your potential risk and understand
Continue Reading Coronavirus Disease 2019 and Force Majeure Contract Clauses

The United States Attorney’s Office for the Southern District of Florida announced on Sept. 19, 2019, that it settled a qui tam False Claims Act case in which a private
Continue Reading 2 Recent Cases Impacting False Claims Act Litigation and Investigations Deserve the Attention of Health Care Providers and Private Equity Investors

san-francisco_image

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many
Continue Reading GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco

Decisions by the U.S. Food and Drug Administration (FDA) have a tremendous impact on Israeli-based medical and pharmaceutical companies that manufacture products that are marketed and sold in the United
Continue Reading Draft Guidances Propose Reduced FDA Oversight of General Wellness Products and Medical Device Accessories